Update AG Company Profile

00:17 EDT 23rd September 2018 | BioPortfolio



Seefeldstrasse 5a


Phone: 044 266 50 10
Fax: 044 266 50 11

News Articles [366 Associated News Articles listed on BioPortfolio]

“It should not be used by businesses”: Wire CEO on WhatsApp update

Instant messaging service Whatsapp has come under fire after it was revealed that some features of the app’s latest update...Read More... The post “It should not be used by businesses”: Wire CEO...

PreveCeutical Provides Corporate Update

PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H) (the "Company" or "PreveCeutical"), is pleased to provide an update on the Company's progress in its ongoing corporate initiatives. The ...

Update of Treatment Recommendations for Latent Mycobacterium tuberculosis Infection

An update from the CDC recommends broadening the population that can use once-weekly isoniazid plus rifapentine for LMTI.

2017 Atherosclerosis Pipeline Highlights Update –

DUBLIN–(BUSINESS WIRE)–The “Atherosclerosis Pipeline Highlights – 2017 Update” drug pipelines has been added to’s offering. Atherosclerosis P...

2017 Malaria Pipeline Highlights Update –

DUBLIN–(BUSINESS WIRE)–The “Malaria Pipeline Highlights – 2017 Update” drug pipelines has been added to’s offering. Malaria Pipeline Highligh...

Gout Pipeline Highlights – 2017 Update –

DUBLIN–(BUSINESS WIRE)–The “Gout Pipeline Highlights – 2017 Update” drug pipelines has been added to’s offering. Gout Pipeline Highlights ...

An MS Drug Update

Cutting the risk for natalizumab-related PML, update on disability outcomes with ibudilast, and daclizumab pulled from the global market. Medscape Neurology

Aeglea BioTherapeutics Announces Positive Clinical Update

Aeglea BioTherapeutic issued an update on Tuesday for its ongoing Phase 1/2 trial of pegzilarginase in patients with a rare genetic disease, Arginase 1 Deficiency (ARG1-D). The post Aeglea BioTherapeu...

Drugs and Medications [0 Results]


PubMed Articles [418 Associated PubMed Articles listed on BioPortfolio]

Clinical PET/MRI: 2018 Update.

The purpose of this article is to provide an update on clinical PET/MRI, including current and developing clinical indications and technical developments.

Fecal microbial transplantation: an update.

The purpose of this article is to provide an update on recent developments in fecal microbiota transplantation (FMT) in the last year.

An update on autoantibodies in scleroderma.

New research continues to provide important insights into the utility of antibody specificities. This review provides an update of recent findings, and the important insights they provide into disease...

An update on the reasons for placement and replacement of direct restorations.

The aim of this study was to review patterns of restoration placement and replacement. A previous study had been carried out in the late 1990s and this study sought to update the literature in this im...

Correlates of Aggression in Personality Disorders: an Update.

This review article aims at giving an update on studies investigating correlates of aggression in personality disorders during the last 5 years.

Clinical Trials [81 Associated Clinical Trials listed on BioPortfolio]

European Organisation of Research and Treatment (EORTC) Quality of Life Questionnaire (QLQ) Breast Cancer Module Update

The purpose of this study is to update the EORTC QLQ Breast (BR)-23 Module. Since the development of BR-23 published 1996 the standard therapy of breast cancer has changed. New therapies b...

Support Annual Strain Update, Safey and Immnogenicity of an Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008, When Administered to Subjects 18-64 Years Affected by Chronic Diseases.

This phase II, open label, is designed as a seasonal study to support annual strain update evaluating the safety, clinical tolerability and immunogenicity of the 2007-2008 formulation of ...

Sub-study for the Validation and Calibration of Data Regarding Physical Activity, Anthropometry and Diet

This study was an update and amplification of exposure measurements of the EPIC-Potsdam Study, which started in 1994-1998.

A Prospective Double-Blind Study of Retrovir in Early HIV Infection

To evaluate the safety and tolerance of chronic administration of Retrovir (AZT) to adult patients with early manifestations of HIV disease. To assess the efficacy of AZT therapy in the tr...

A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s)

This Phase 4, prospective, multicenter, non-interventional, regulatory post-marketing surveillance study will collect information on the the safety and effectiveness of atezolizumab under ...

Companies [46 Associated Companies listed on BioPortfolio]

update CRM Inc.

update CRM Inc. provides innovative and unique cloud-based customer relationship management (CRM) solutions to a growing number of small and large life sciences companies in the U...

Update AG


Update Pharma Inc.

Update Pharma Inc. is developing UPI-928, an agent developed in the 1980’s by Lederle Laboratories in 44 phase 1, 2 and 3 clinical trials, including 33 clinical trials at the...

The Hartford Income Shares Fund, Inc.

This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act, with respect to the fund’s future financial or b...


WHAT:2012 Annual Meeting featuring Gov. Robert Bentley, an update of the BioAlabama Five Year Strategic Plan and presentation of Biotechnology Resolution by Sen. Jabo Waggoner and...

More Information about "Update AG" on BioPortfolio

We have published hundreds of Update AG news stories on BioPortfolio along with dozens of Update AG Clinical Trials and PubMed Articles about Update AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Update AG Companies in our database. You can also find out about relevant Update AG Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record